Skip to main content

Table 1 Main clinical characteristics of PD patients

From: Structural alterations of the intestinal epithelial barrier in Parkinson’s disease

 

Age

Sex

Disease duration (years)

Cumulative lifetime dose of L-dopa (mg)

1

70

F

2

0

2

64

M

NK

NK

3

70

M

NK

NK

4

66

M

23

66111000

5

47

F

2

0

6

62

M

4

3823375

7

74

M

13

1505625

8

53

M

4

2372500

9

69

M

2.5

273750

10

43

F

11

508050

11

67

M

2.3

0

12

58

M

7

2135250

13

58

M

9

1533000

14

72

F

14

1442662.5

15

64

M

4

492750

16

64

M

10

355875

17

56

M

NK

NK

18

66

M

4.6

0

19

62

M

26

1560375

20

70

F

2.2

219000

21

57

M

1.8

0

22

58

M

13

2007500

23

50

M

8

1286625

24

69

F

28

3759500

25

62

M

8

511000

26

56

F

8

1241000

27

46

M

10

1213625

28

56

F

8.4

866875

29

58

F

4.8

447125

30

54

M

24

3085423

31

58

M

10

3374130

  1. NK: not known.